FDA Inspection 1046315 — Mario Campone, MD, PhD
The FDA completed an inspection of Mario Campone, MD, PhD on Dec 22, 2017 in Saint-Herblain. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 22, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint-Herblain (France)
Additional details
Clinical Investigator (CI)